Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2014 4
2015 1
2016 2
2018 1
2021 3
2022 1
2024 1
2025 2
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
The following term was ignored: %
Page 1
Efinaconazole in Onychomycosis.
Gupta AK, Talukder M. Gupta AK, et al. Am J Clin Dermatol. 2022 Mar;23(2):207-218. doi: 10.1007/s40257-021-00660-1. Epub 2021 Dec 13. Am J Clin Dermatol. 2022. PMID: 34902110 Review.
Efinaconazole 10% topical solution is an FDA-approved treatment for onychomycosis patients aged 6 years and above. ...Altogether, phase I and phase III clinical trials, and post-hoc analyses indicate that efinaconazole 10% t …
Efinaconazole 10% topical solution is an FDA-approved treatment for onychomycosis patients aged 6 years and above. ...A …
Topical Efinaconazole 10% for Onychomycosis: Pooled Phase 3 Analysis in White, Black, and Asian Participants.
Lipner SR, Gupta AK, Vlahovic TC, Rosen T, Elewski B, Choi SY, Guenin E, Gold LS. Lipner SR, et al. J Drugs Dermatol. 2026 Jan 1;25(1):67-74. doi: 10.36849/JDD.9384. J Drugs Dermatol. 2026. PMID: 41493257 Clinical Trial.
BACKGROUND: Topical efinaconazole 10% solution has demonstrated efficacy and safety in two phase 3 trials of onychomycosis. ...CONCLUSIONS: Topical efinaconazole 10% showed favorable efficacy/safety in White, Asian, and Black participants …
BACKGROUND: Topical efinaconazole 10% solution has demonstrated efficacy and safety in two phase 3 trials of onychom …
Efficacy and Safety of Efinaconazole 10% Topical Solution for Treatment of Onychomycosis in Older Adults: A Post Hoc Analysis of Two Phase 3 Randomised Trials.
Lipner SR, Gupta AK, Joseph WS, Elewski B, Guenin E, Vlahovic TC. Lipner SR, et al. Mycoses. 2025 May;68(5):e70069. doi: 10.1111/myc.70069. Mycoses. 2025. PMID: 40396391 Free PMC article. Clinical Trial.
Oral treatments can be complicated by contraindications, drug-drug interactions, and adverse effects. Topical treatments such as efinaconazole 10% solution may be beneficial for treating older adults. OBJECTIVES: To evaluate the efficacy/safety of efinaconazole …
Oral treatments can be complicated by contraindications, drug-drug interactions, and adverse effects. Topical treatments such as efinacon …
Efinaconazole 10% solution in the treatment of onychomycosis of the toenails.
Joseph WS, Vlahovic TC, Pillai R, Olin JT. Joseph WS, et al. J Am Podiatr Med Assoc. 2014 Sep-Oct;104(5):479-85. doi: 10.7547/0003-0538-104.5.479. J Am Podiatr Med Assoc. 2014. PMID: 25275736
BACKGROUND: Efinaconazole 10% solution is a new triazole antifungal agent developed for the topical treatment of onychomycosis. ...CONCLUSIONS: The efficacy and safety profile of efinaconazole 10% solution suggests that it may represent an impor …
BACKGROUND: Efinaconazole 10% solution is a new triazole antifungal agent developed for the topical treatment of onychomyco …
Efinaconazole 10% topical solution for the topical treatment of onychomycosis of the toenail.
Lipner SR, Scher RK. Lipner SR, et al. Expert Rev Clin Pharmacol. 2015;8(6):719-31. doi: 10.1586/17512433.2015.1083418. Epub 2015 Aug 31. Expert Rev Clin Pharmacol. 2015. PMID: 26325488 Review.
Efinaconazole 10% topical solution is a new antifungal therapy for the topical treatment of mild to moderate toenail onychomycosis. ...In two parallel, double-blind, randomized, controlled, Phase III trials, complete cure rates were 17.8 and 15. …
Efinaconazole 10% topical solution is a new antifungal therapy for the topical treatment of mild to moderate toenail onycho …
Update on Efinaconazole 10% Topical Solution for the Treatment of Onychomycosis.
Gupta AK, Studholme C. Gupta AK, et al. Skin Therapy Lett. 2016 Nov;21(6):7-11. Skin Therapy Lett. 2016. PMID: 27825175 Free article.
Efinaconazole 10% nail solution is a novel topical antifungal drug for the treatment of onychomycosis. Two Phase III trials were completed using efinaconazole 10% nail solution, where 17.8% and 15.2% of patients achieved complete c …
Efinaconazole 10% nail solution is a novel topical antifungal drug for the treatment of onychomycosis. Two Phase …
Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies.
Elewski BE, Rich P, Pollak R, Pariser DM, Watanabe S, Senda H, Ieda C, Smith K, Pillai R, Ramakrishna T, Olin JT. Elewski BE, et al. J Am Acad Dermatol. 2013 Apr;68(4):600-608. doi: 10.1016/j.jaad.2012.10.013. Epub 2012 Nov 20. J Am Acad Dermatol. 2013. PMID: 23177180 Clinical Trial.
OBJECTIVE: We investigated the safety and efficacy of efinaconazole 10% solution (efinaconazole), the first triazole antifungal developed for distal lateral subungual onychomycosis. ...CONCLUSIONS: Once daily topical efinaconazole appears to be …
OBJECTIVE: We investigated the safety and efficacy of efinaconazole 10% solution (efinaconazole), the first triazole an …
The efficacy and safety of efinaconazole 10% solution for treatment of mild to moderate onychomycosis: a pooled analysis of two phase 3 randomized trials.
Gupta AK, Elewski BE, Sugarman JL, Ieda C, Kawabata H, Kang R, Pillai R, Olin JT, Watanabe S. Gupta AK, et al. J Drugs Dermatol. 2014 Jul;13(7):815-20. J Drugs Dermatol. 2014. PMID: 25007364
OBJECTIVES: To investigate the efficacy and safety of efinaconazole 10% solution in pooled Phase III clinical trial participants with mild to moderate onychomycosis. ...CONCLUSIONS: The findings from this pooled analysis suggest that efinacon …
OBJECTIVES: To investigate the efficacy and safety of efinaconazole 10% solution in pooled Phase III clinical tr …
One size does not fit all: the need for individualized treatment based on factors that may affect the therapeutic outcome of efinaconazole 10% solution for the treatment of toenail onychomycosis.
Gupta AK, Venkataraman M, Anbalagan N, Guenin EP. Gupta AK, et al. Int J Dermatol. 2021 Oct;60(10):1296-1302. doi: 10.1111/ijd.15739. Epub 2021 Jul 3. Int J Dermatol. 2021. PMID: 34216026 Review.
Successful management of onychomycosis is a challenge because cure rates with most antifungals are relatively low and recurrence rates are high. ...Here, we review the post hoc analyses of the phase III trials of efinaconazole 10% solution that …
Successful management of onychomycosis is a challenge because cure rates with most antifungals are relatively low and recurrence rate …
Efinaconazole (Jublia) for the treatment of onychomycosis.
Gupta AK, Simpson FC. Gupta AK, et al. Expert Rev Anti Infect Ther. 2014 Jul;12(7):743-52. doi: 10.1586/14787210.2014.919852. Epub 2014 May 22. Expert Rev Anti Infect Ther. 2014. PMID: 24850511
Efinaconazole 10% nail solution (Jublia( )) is a new topical triazole antifungal designed for the topical treatment of distal and lateral subungual onychomycosis. ...Safety studies have shown that this formulation is not associated with atopic dermatitis or c …
Efinaconazole 10% nail solution (Jublia( )) is a new topical triazole antifungal designed for the topical treatment of distal …
16 results